1型糖尿病的筛查与预防:现状与展望
本文为小型综述,聚焦1型糖尿病(T1D)筛查与预防的当前格局。文章指出,早期识别症状前T1D可准确预测临床发病,结合教育与监测可改善健康结局;不断增多的有效疾病修饰疗法具有改变T1D早期自然史的潜力。文章同时讨论了该领域面临的挑战与未来方向。
要点
- 早期识别症状前T1D可准确预测临床发病,结合教育与监测可改善健康结局。
- 不断增多的有效疾病修饰疗法具有改变T1D早期自然史的潜力。
- 本文综述了推动当前T1D筛查与预防格局的既往工作、挑战及未来方向。
核心结论
- 早期识别症状前T1D可准确预测临床发病,结合教育与监测可改善健康结局;不断增多的有效疾病修饰疗法具有改变T1D早期自然史的潜力。
研究设计与样本
- 本文为小型综述,回顾推动当前T1D筛查与预防格局的既往工作、挑战及未来方向。
主要发现
- 大量工作提示,早期识别症状前T1D可准确预测临床发病,结合教育与监测可改善健康结局。
- 不断增多的有效疾病修饰疗法具有改变T1D早期自然史的潜力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A diagnosis of type 1 diabetes (T1D) and the subsequent requirement for exogenous insulin treatment is associated with considerable acute and chronic morbidity and a substantial effect on patient quality of life. Importantly, a large body of work suggests that early identification of presymptomatic T1D can accurately predict clinical disease, and when paired with education and monitoring, can yield improved health outcomes. Furthermore, a growing cadre of effective disease-modifying therapies provides the potential to alter the natural history of early stages of T1D. In this mini review, we highlight prior work that has led to the current landscape of T1D screening and prevention, as well as challenges and next steps moving into the future of these rapidly evolving areas of patient care.
引用
- Simmons KM, Sims EK. Screening and Prevention of Type 1 Diabetes: Where Are We? J Clin Endocrinol Metab. 2023. PMID: 37290044. doi:10.1210/clinem/dgad328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。